GENinCode Inkomsten in het verleden
Verleden criteriumcontroles 0/6
GENinCode's earnings have been declining at an average annual rate of -36.8%, while the Healthcare industry saw earnings growing at 31.3% annually. Revenues have been growing at an average rate of 30.5% per year.
Belangrijke informatie
-36.8%
Groei van de winst
28.0%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 12.6% |
| Inkomstengroei | 30.5% |
| Rendement op eigen vermogen | -211.2% |
| Nettomarge | -228.7% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe GENinCode geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 3 | -6 | 7 | 0 |
| 31 Mar 24 | 2 | -6 | 7 | 0 |
| 31 Dec 23 | 2 | -7 | 8 | 0 |
| 30 Sep 23 | 2 | -7 | 8 | 0 |
| 30 Jun 23 | 2 | -7 | 8 | 0 |
| 31 Mar 23 | 2 | -6 | 7 | 0 |
| 31 Dec 22 | 1 | -6 | 6 | 0 |
| 30 Sep 22 | 1 | -6 | 6 | 0 |
| 30 Jun 22 | 1 | -5 | 5 | 0 |
| 31 Mar 22 | 1 | -5 | 5 | 0 |
| 31 Dec 21 | 1 | -4 | 4 | 0 |
| 30 Sep 21 | 1 | -3 | 3 | 0 |
| 30 Jun 21 | 1 | -2 | 2 | 0 |
| 31 Mar 21 | 1 | -1 | 2 | 0 |
| 31 Dec 20 | 1 | -1 | 2 | 0 |
| 31 Dec 19 | 1 | 0 | 1 | 0 |
Kwaliteitswinsten: GENI is currently unprofitable.
Groeiende winstmarge: GENI is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: GENI is unprofitable, and losses have increased over the past 5 years at a rate of 36.8% per year.
Versnelling van de groei: Unable to compare GENI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: GENI is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (12.1%).
Rendement op eigen vermogen
Hoge ROE: GENI has a negative Return on Equity (-211.23%), as it is currently unprofitable.